Bayer Secures FDA Approval for Lung Cancer Drug Hyrnuo
Bayer AG has received approval from the US Food and Drug Administration (FDA) for its new medication, Hyrnuo, targeted at treating a prevalent form of lung cancer. This approval is…
Breaking News & Top Stories
Bayer AG has received approval from the US Food and Drug Administration (FDA) for its new medication, Hyrnuo, targeted at treating a prevalent form of lung cancer. This approval is…